Ignite Creation Date:
2025-12-24 @ 9:22 PM
Ignite Modification Date:
2025-12-25 @ 7:09 PM
Study NCT ID:
NCT04713904
Status:
COMPLETED
Last Update Posted:
2021-04-15
First Post:
2021-01-14
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Bioavailability of Clormadinone/Ethinyl Estradiol Tablets 2 mg/0.02 mg With Regards to Reference Product
Sponsor:
Laboratorios Andromaco S.A.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-01-16
Start Date Type:
ACTUAL
Primary Completion Date:
2021-01-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-02-02
Completion Date Type:
ACTUAL
First Submit Date:
2021-01-14
First Submit QC Date:
None
Study First Post Date:
2021-01-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-04-13
Last Update Post Date:
2021-04-15
Last Update Post Date Type:
ACTUAL